首页> 美国卫生研究院文献>Rheumatology (Oxford England) >Corrigendum to: Obesity reduces the real-world effectiveness of cytokine-targeted but not cell-targeted disease-modifying agents in rheumatoid arthritis

【2h】

Corrigendum to: Obesity reduces the real-world effectiveness of cytokine-targeted but not cell-targeted disease-modifying agents in rheumatoid arthritis

机译：勘测：肥胖降低了类细胞靶靶向但不是类风湿性关节炎的细胞靶向疾病改性剂的真实效力

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Rheumatology 2020;59:1916–1926. doi:

著录项

期刊名称 Rheumatology (Oxford England)
作者
Martin Schäfer; Yvette Meißner; Jörn Kekow; Sylvia Berger; Sven Remstedt; Bernhard Manger; Joachim Listing; Anja Strangfeld; Angela Zink;
展开▼
作者单位

展开▼
年(卷),期 -1(59),8
年度 -1
页码 -1
总页数 1
原文格式 PDF
正文语种
中图分类免疫性疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Real-World Analysis of Cost-Effectiveness among Patients with Rheumatoid Arthritis who Switched from a Tumor Necrosis Factor Inhibitor to Another Targeted Disease-Modifying Antirheumatic Drug [J] . Bonafede Machaon, Wei Wenhui, Chen Chieh-I, The Journal of rheumatology . 2017,第6期

机译：从肿瘤坏死因子抑制剂转换为另一种靶向疾病改性的抗胃癌的类风湿性关节炎患者成本效益的实际分析
2. Real-world Effectiveness of Biologic Disease-modifying Antirheumatic Drugs for the Treatment of Rheumatoid Arthritis After Etanercept Discontinuation in the United Kingdom, France, and Germany [J] . Li Nanxin, Betts Keith A., Messali Andrew J., Clinical therapeutics . 2017,第8期

机译：生物疾病改性抗逆素药物治疗英国，法国，法国和德国的etanercept indontination后的类风湿性关节炎的真实效力
3. Treatment of Very Early Rheumatoid Arthritis With Symptomatic Therapy, Disease-Modifying Antirheumatic Drugs, or Biologic Agents: A Cost-Effectiveness Analysis [J] . Axel Finckh Nick Bansback Carlo A. Marra Aslam H. Anis Kaleb Michaud Stanley Lubin Marc White Sonia Sizto and Matthew H. Liang Annals of Internal Medicine . 2009,第9期

机译：对症治疗，改良疾病的抗风湿药或生物制剂治疗早期类风湿关节炎的成本效益分析
4. Predicting therapeutic outcomes in Rheumatoid Arthritis using real-world pharmacogenetic and clinical data [C] . Fabián Hernández, Luis Fernando Niño, Fabio Aristizábal IEEE International Conference on Bioinformatics and Biomedicine . 2020

机译：使用现实世界药物原和临床数据预测类风湿性关节炎的治疗结果
5. Predictors of Infection in Rheumatoid Arthritis Patients Using Anti-Tumor Necrosis Factor Agents [D] . Liu, Tasia 2017

机译：类风湿关节炎患者使用抗肿瘤坏死因子药物的感染预测因子
6. Obesity reduces the real-world effectiveness of cytokine-targeted but not cell-targeted disease-modifying agents in rheumatoid arthritis [O] . Martin Schäfer, Yvette Meißner, Jörn Kekow, -1

机译：肥胖降低了细胞因子靶向但不是类风湿性关节炎中细胞靶向疾病改性剂的真实效果
7. Real-world Effectiveness of Biologic Disease-modifying Antirheumatic Drugs for the Treatment of Rheumatoid Arthritis After Etanercept Discontinuation in the United Kingdom, France, and Germany [O] . Nanxin Li, Keith A. Betts, Andrew J. Messali, 2017

机译：生物疾病改性抗逆素药物治疗英国，法国，法国和德国的etanercept indontination后的类风湿性关节炎的真实效力

Corrigendum to: Obesity reduces the real-world effectiveness of cytokine-targeted but not cell-targeted disease-modifying agents in rheumatoid arthritis

摘要

著录项

相似文献

相关主题

期刊订阅